Dr. Reddy’s Laboratories – Pharma Watch

Important Levels: Support: ₹1,170 – ₹1,140 Resistance: ₹1,230 – ₹1,260 Structure: Recovery attempt after a prolonged correction Business: Global pharmaceutical company with exposure to generics, APIs, biosimilars and differentiated products. Strong presence across India, North America and emerging markets. Earnings / Trigger: Dr. Reddy’s remains among the stocks in focus today amid fresh company-specific developments and the broader pharma sector's earnings activity. The stock closed around ₹1,202 on Friday, remaining below its June 52-week high of ₹1,414.40. Verdict: 👉 Quality pharma name with recovery potential